US OptionsDetailed Quotes

SYRE241220C45000

Watchlist

1.85
0.000.00%

15min DelayClose Nov 21 16:00 ET

0.00High0.00Low

Spyre Therapeutics Stock Discussion

Jaguar8

Nov 18 20:56

NEWS

$Spyre Therapeutics (SYRE.US)$
Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Spyre Therapeutics (NASDAQ: SYRE) has priced its public offering of 7,275,000 common stock shares at $27.50 per share, expecting to raise $200.0 million in gross proceeds. The clinical-stage biotech company, focused on IBD treatments, has granted underwriters a 30-day option to purchase up to additional 1,091,250 shares. The offering, managed by Jefferies, Goldman Sachs, Evercor...

Bull X Bear

Oct 11 11:12

US Market Movers

Banks: $JPMorgan (JPM.US)$ $Wells Fargo & Co (WFC.US)$ $Bank of America (BAC.US)$
Capital Markets: $UP Fintech (TIGR.US)$ $Cipher Mining (CIFR.US)$ $CleanSpark (CLSK.US)$
Biotechnology: $Genfit (GNFT.US)$ $Spyre Therapeutics (SYRE.US)$ $Krystal Biotech (KRYS.US)$
Software: $Verb Technology (VERB.US)$ $SurgePays (SURG.US)$ $Uber Technologies (UBER.US)$
Asset Management: $Westwood Holdings (WHG.US)$ $BrightSphere Investment (BSIG.US)$ $Blackrock (BLK.US)$
Specialty Industrial Machinery: $JE Cleantech Holdings Limited (JCSE.US)$ $Taylor Devices (TAYD.US)$ $CSW Industrials (CSWI.US)$
...

108S

Jun 11 11:15

$Spyre Therapeutics (SYRE.US)$ will it rise?

Rocketier (MAXN)

May 29 13:03

$Spyre Therapeutics (SYRE.US)$ it's seems like the past mp ranged around 100-300, but not sure why there's a sudden huge crash in price. Do u guys think it can get back to the past price?

Moomoo Recap US

Jan 22 15:13

Columns Wall Street Street | Great Day For Volume Stocks on Fresh Index Records

RECAP
U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season.
The $Dow Jones Industrial Average (.DJI.US)$ rose 138 points, or 0.26%, to 38,000. The $S&P 500 Index (.SPX.US)$ was up 10 points, or 0.22%, at 4,850. The $Nasdaq Composite Index (.IXIC.US)$advanced 49 points, or 0.32%, to 15,360.
While the S&P 500 finally returned to record territory on Friday, skeptic...

Kevin Travers

Jan 22 09:51

Columns BiotTech Rises with the Index Tide

After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were $Spyre Therapeutics (SYRE.US)$, up 26% Monday morning, and $Gyre Therapeutics (GYRE.US)$ +10%.
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks (DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...

AmyNic

Nov 28, 2023 13:56

Halted

$Spyre Therapeutics (SYRE.US)$

No comment yet